uniQure (QURE) Share-based Compensation (2016 - 2026)
uniQure (QURE) posted quarterly Share-based Compensation of $40.8 million for Q2 2026, up 407660.0% year-over-year from N/an in Q2 2025, and up 701.1% quarter-over-quarter from $5.1 million in Q1 2026.
uniQure (QURE) Share-based Compensation (2016 - 2026) Analysis & Trends
uniQure's Share-based Compensation history runs 11 years deep, the most recent figure standing at $40.8 million for Q2 2026.
- In Q2 2026, Share-based Compensation rose 407660.0% year-over-year to $40.8 million; the TTM figure through Jun 2026 stood at $40.8 million (up 344.81% YoY), while the FY2025 annual figure was $32.3 million, up 45.03% from the prior year.
- Share-based Compensation for Q2 2026 stood at $40.8 million, up from $5.1 million in the prior quarter.
- The five-year high for Share-based Compensation was $40.8 million in Q2 2026, with the low at -$2000.0 in Q3 2024.
- The 5-year median for Share-based Compensation is $7.0 million (2022), against an average of $7.6 million.
- The sharpest annual moves came in 2024 and 2026: Share-based Compensation plunged 100.02% in 2024, then soared 407660.0% in 2026.
- uniQure's Share-based Compensation stood at $11.9 million in 2022, then sank by 40.9% to $7.0 million in 2023, then plunged by 32.55% to $4.7 million in 2024, then slipped by 1.81% to $4.7 million in 2025, then surged by 774.46% to $40.8 million in 2026.
- Business Quant data shows QURE's Share-based Compensation at $40.8 million in Q2 2026, $5.1 million in Q1 2026, and $4.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 108.10 Mn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 243.00 Mn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | - |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | 277.20 Mn |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 137.41 Mn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 590,899.88 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 86.63 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 41.25 Mn |
| 10 | uniQure | 3.37 Bn | 3.37 Bn | 5.49 Mn | 40.78 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 40.78 Mn |
| Jun 30, 2026 | 40.78 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Mar 31, 2026 | 5.09 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Dec 31, 2025 | 4.66 Mn |
| Sep 30, 2025 | -2,000.00 |
| Sep 30, 2025 | -2,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Jun 30, 2025 | 10,000.00 |
| Mar 31, 2025 | 4.41 Mn |
| Mar 31, 2025 | 4.41 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Dec 31, 2024 | 4.75 Mn |
| Sep 30, 2024 | -2,000.00 |
| Sep 30, 2024 | -2,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Jun 30, 2024 | 10,000.00 |
| Mar 31, 2024 | 7.19 Mn |
| Mar 31, 2024 | 7.19 Mn |